These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32039859)

  • 21. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe.
    Bladen CL; Thompson R; Jackson JM; Garland C; Wegel C; Ambrosini A; Pisano P; Walter MC; Schreiber O; Lusakowska A; Jedrzejowska M; Kostera-Pruszczyk A; van der Pol L; Wadman RI; Gredal O; Karaduman A; Topaloglu H; Yilmaz O; Matyushenko V; Rasic VM; Kosac A; Karcagi V; Garami M; Herczegfalvi A; Monges S; Moresco A; Chertkoff L; Chamova T; Guergueltcheva V; Butoianu N; Craiu D; Korngut L; Campbell C; Haberlova J; Strenkova J; Alejandro M; Jimenez A; Ortiz GG; Enriquez GV; Rodrigues M; Roxburgh R; Dawkins H; Youngs L; Lahdetie J; Angelkova N; Saugier-Veber P; Cuisset JM; Bloetzer C; Jeannet PY; Klein A; Nascimento A; Tizzano E; Salgado D; Mercuri E; Sejersen T; Kirschner J; Rafferty K; Straub V; Bushby K; Verschuuren J; Beroud C; Lochmüller H
    J Neurol; 2014 Jan; 261(1):152-63. PubMed ID: 24162038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany.
    Landfeldt E; Leibrock B; Hussong J; Thiele S; Abner S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
    J Neuromuscul Dis; 2024; 11(1):117-128. PubMed ID: 38108360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.
    Chali F; Desseille C; Houdebine L; Benoit E; Rouquet T; Bariohay B; Lopes P; Branchu J; Della Gaspera B; Pariset C; Chanoine C; Charbonnier F; Biondi O
    J Physiol; 2016 Apr; 594(7):1931-52. PubMed ID: 26915343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.
    Cruz R; Belter L; Wasnock M; Nazarelli A; Jarecki J
    Clin Ther; 2019 May; 41(5):943-960.e4. PubMed ID: 31056304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
    Pacione M; Siskind CE; Day JW; Tabor HK
    J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].
    Castiglioni C; Levicán J; Rodillo E; Garmendia MA; Díaz A; Pizarro L; Contreras L
    Rev Med Chil; 2011 Feb; 139(2):197-204. PubMed ID: 21773657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study.
    De Vivo DC; Bertini E; Swoboda KJ; Hwu WL; Crawford TO; Finkel RS; Kirschner J; Kuntz NL; Parsons JA; Ryan MM; Butterfield RJ; Topaloglu H; Ben-Omran T; Sansone VA; Jong YJ; Shu F; Staropoli JF; Kerr D; Sandrock AW; Stebbins C; Petrillo M; Braley G; Johnson K; Foster R; Gheuens S; Bhan I; Reyna SP; Fradette S; Farwell W;
    Neuromuscul Disord; 2019 Nov; 29(11):842-856. PubMed ID: 31704158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant healthcare burden and life cost of spinal muscular atrophy: real-world data.
    Chan SHS; Wong CKH; Wu T; Wong W; Yu MKL; Au ICH; Chan GCF
    Eur J Health Econ; 2023 Nov; 24(8):1373-1382. PubMed ID: 36403177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device-Perspective of available/ongoing registries of catheter-based LAA occlusion.
    Hildick-Smith D; Diener HC; Schmidt B; Paul V; Settergren M; Teiger E; Camm J; Tondo C; Landmesser U
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):540-547. PubMed ID: 28862376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy.
    Burns JK; Kothary R; Parks RJ
    Neuromuscul Disord; 2016 Sep; 26(9):551-9. PubMed ID: 27460292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study.
    Vázquez-Costa JF; Branas-Pampillón M; Medina-Cantillo J; Povedano M; Pitarch-Castellano I; López-Lobato M; Fernández-Ramos JA; Lafuente-Hidalgo M; Rojas-García R; Caballero-Caballero JM; Málaga I; Eirís-Puñal J; De Lemus M; Cattinari MG; Cabello-Moruno R; Díaz-Abós P; Sánchez-Menéndez V; Rebollo P; Maurino J; Madruga-Garrido M
    Neurol Ther; 2023 Feb; 12(1):89-105. PubMed ID: 36269538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
    Paller CJ; Barata PC; Lorentz J; Appleman LJ; Armstrong AJ; DeMarco TA; Dreicer R; Elrod JAB; Fleming M; George C; Heath EI; Hussain MHA; Mao S; McKay RR; Morgans AK; Orton M; Pili R; Riedel E; Saraiya B; Sigmond J; Sokolova A; Stadler WM; Tran C; Macario N; Vinson J; Green R; Cheng HH;
    Prostate; 2024 Feb; 84(3):292-302. PubMed ID: 37964482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives.
    Ch'ng GS; Koh K; Ahmad-Annuar A; Taib F; Koh CL; Lim ESC
    Orphanet J Rare Dis; 2022 May; 17(1):200. PubMed ID: 35578241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy.
    Messina S; Frongia AL; Antonaci L; Pera MC; Coratti G; Pane M; Pasternak A; Civitello M; Montes J; Mayhew A; Finkel R; Muntoni F; Mercuri E;
    Neuromuscul Disord; 2019 Dec; 29(12):940-950. PubMed ID: 31791871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances and challenges in developing a therapy for spinal muscular atrophy.
    Anderton RS; Mastaglia FL
    Expert Rev Neurother; 2015; 15(8):895-908. PubMed ID: 26200127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
    Sun Y; Kong X; Zhao Z; Zhao X
    BMC Med Genet; 2020 Jun; 21(1):133. PubMed ID: 32552676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.